Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer.
Mahmoud A ElshenawyAhmed BadranAli AljubranAhmed AlzahraniM Shahzad RaufAbdelmoneim EldaliShouki BazarbashiPublished in: World journal of surgical oncology (2020)
Clinicaltrials.gov , NCT01311050 , registered March 6, 2011, retrospectively registered.